Literature DB >> 8051761

Metastatic renal cell carcinoma arising in a native kidney of a renal transplant recipient.

T Nakamoto1, M Igawa, S Mitani, M Ueda, A Usui, T Usui.   

Abstract

We report a case of metastatic renal cell carcinoma arising in the native kidney of a renal transplant recipient. A 39-year-old man, who had undergone living renal transplantation from his mother at age 32, presented with complaints of paraplegia of the leg caused by a pathological fracture of the 3rd lumbar vertebra. The bone tumor was extirpated and pathological examination revealed metastatic adenocarcinoma. Abdominal computerized tomography showed a tumor in the right native kidney. Right nephrectomy and resection of the right 7th rib tumor were performed. Pathological evaluation demonstrated renal cell carcinoma of the right native kidney (pT2bpN0pV0M1, mixed cell type, grade 2). Postoperatively, cyclosporine was discontinued and natural interferon-alpha was given. The remaining bone metastasis had completely resolved with no significant sign of rejection 1 year after surgery.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8051761     DOI: 10.1016/s0022-5347(17)32617-4

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  3 in total

1.  The incidence of tumours in renal transplant recipients with long-term immunosuppressive therapy.

Authors:  D Ondrus; V Pribylincová; J Breza; P Bujdák; M Miklosi; J Reznícek; V Zvara
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

2.  Multidisciplinary treatment including sorafenib stabilized the bone metastases of renal cell carcinoma in an immunosuppressed renal transplant recipient.

Authors:  Yasuhisa Hasegawa; Koji Mita; Akio Matsubara; Hideki Ohdan
Journal:  Int J Clin Oncol       Date:  2009-10-25       Impact factor: 3.402

3.  Metastatic renal cell carcinoma of the native kidney in a renal transplant recipient: Revisiting the era of tyrosine kinase inhibitors - Case report.

Authors:  Daniel Suso-Palau; Julián Chavarriaga; Francisco Usubillaga; Josué Asprilla; Lina Micolta; Marcela Urrego
Journal:  Urol Case Rep       Date:  2022-04-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.